Adaptive Biotechnologies

Founded in 2009, Adaptive is at the forefront of immune-based discoveries, combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. They bring the accuracy and sensitivity of their immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases.